Pick Insider Trading in Facebook, Micron, Oracle, Boston Scientific, Sirius XM Radio, and Crocs



Insiderslab.com is has released insider trading report as the following stocks: Facebook (NASDAQ:FB), Micron (NASDAQ:MU), Oracle (NYSE:ORCL), Boston Scientific (NYSE:BSX), Sirius XM Radio (NASDAQ:SIRI), and Crocs (NASDAQ:CROX).
 
(Read full report by clicking the link below, you may need to copy and paste the full link to your browser.)
 
Report Highlights:
 
Facebook Inc (NASDAQ:FB): By the end of last trading session, the shares of Facebook (NASDAQ:FB) surged US$7.85 (or 29.61%) to US$34.36 with 365.94 million shares exchanged hands, compared to daily average volume of 32.97 million. The company reported a exited Q2 earnings since it pushed aggressively into mobile advertising. Insiderslab.com found company VP, Gen. Counsel & Secretary, Colin Stretch, sold his shares at price of US$33.51 on July 25. Investors may want to find out how Yahoo insiders like CEOs, CFOs and Directors are thinking about the future of the company. Check this insider trade report for YHOO here.
 
Read Full Report: http://www.insiderslab.com/PR3/072613A/FB/Facebook.pdf
 
Micron Technology, Inc. (NASDAQ:MU): By the end of last trading session, Micron (NASDAQ:MU) shares earned 1.41% to US$13.29 with about 42.70 million shares exchanged hands for the session, compared to its average volume of 46.94 million shares. Insiderslab.com found company insiders sold his/her shares at price of US$9.26 – US$14.52 for about US$21.13 million within the last three months. Investors may want to find out how Micron insiders like CEOs, CFOs and Directors are thinking about the future of the company.
 
Read Full Report: http://www.insiderslab.com/PR3/072613A/MU/Micron.pdf
 
Oracle Corporation (NYSE:ORCL): By the end of last trading session, Oracle (NYSE:ORCL) lost 0.06% to US$32.37 with about 21.05 million shares exchanged hands for the session, compared to its average volume of 37.64 million shares. Insiderslab.com found company Director, Safra Catz, sold her shares at price of US$32.22 for about US$32.22 million on July 17. Insiderslab.com believes that it is a clever way to check if insiders like CEOs, CFOs, and Directors in Oracle are starting to sell more company shares. See insider trade report for ORCL here.
 
Read Full Report: http://www.insiderslab.com/PR3/072613A/ORCL/Oracle.pdf
 
Today Insiderslab.com also observed abnormal trade volume for the following companies; insiders may involve trading in these companies. It will take some time for insiders to report their trades. Read these reports and add these companies into your Insider Trade Radar.
 
Boston Scientific Corporation (NYSE:BSX):
 
Read Full Report: http://www.insiderslab.com/PR3/072613A/BSX/BostonScientific.pdf
 
Sirius XM Radio Inc (NASDAQ:SIRI):
 
Read Full Report: http://www.insiderslab.com/PR3/072613A/SIRI/SiriusXMRadio.pdf
 
Crocs, Inc. (NASDAQ:CROX):
 
Read Full Report: http://www.insiderslab.com/PR3/072613A/CROX/Crocs.pdf
 
Insider Filing Source Reference: All observations, analysis and reports are based on public information released by the U.S. Securities and Exchange Commission.
 
About Insiderslab.com:
 
Insiderslab.com covers insider trade data in major stock markets in the U.S., Hong Kong, Mainland China, and Singapore.  Insiderslab.com features a team of experienced data analysts striving to provide the investment community with the tools, software, and data necessary to carry out more effective investment research.
 
Important Disclaimer:
Please visit insiderslab.com/disclaimers/disclaimers.php for details.
Source:
www.insiderslab.com
www.insiderslab.com

Reported on Jul 26, 2013

 
More Insider News ...

Today's Notable Trades


PIER 1 IMPORTS INC/DE (PIR)
Senior Officer (Exec Vice Pres/Human Resources): Humenesky Gregory

Acquired 25,000 common stock (Non-Derivative security at $7.450) on Apr 11, 2014. Direct holding 131,458 shares/units after transaction. Holdings increased 23.48%.
Filing date: Apr 15, 2014. Record updated at 22:30:49.
 
PDL BIOPHARMA, INC. (PDLI)
Senior Officer (President, CEO): MCLAUGHLIN JOHN PETER

Acquired 119,770 Common stock (Non-Derivative security at $8.220) on Apr 10, 2014. Direct holding 288,468 shares/units after transaction. Holdings increased 71.00%.
Filing date: Apr 15, 2014. Record updated at 22:30:32.
 
PENNYMAC FINANCIAL SERVICES, INC. (PFSI)
Director: Botein Matthew

Sold 21,118 Class A Common Stock (Non-Derivative security at $16.230) on Apr 14, 2014. Direct holding 83,341 shares/units after transaction. Holdings decreased -20.22%.
Filing date: Apr 15, 2014. Record updated at 22:21:52.
 
Cerulean Pharma Inc. (CERU)
Other: Lux Capital Management, LLC

Acquired 106,224 Common Stock (Non-Derivative security at $7.000) on Apr 15, 2014. Direct holding 951,999 shares/units after transaction. Holdings increased 12.56%.
Filing date: Apr 15, 2014. Record updated at 22:18:44.
 
FOREST CITY ENTERPRISES INC (FCEA/FCEB)
Senior Officer (Exec VP & CFO): OBRIEN ROBERT G

Sold 5,400 Class A Common Stock (Non-Derivative security at $18.460) on Apr 13, 2014. Direct holding 32,872 shares/units after transaction. Holdings decreased -14.11%.
Filing date: Apr 15, 2014. Record updated at 22:18:27.
 
QUESTCOR PHARMACEUTICALS INC (QCOR)
First-Class Insider (President and CEO): BAILEY DON M

Acquired 40,000 Common Stock (Non-Derivative security at $5.120) on Apr 14, 2014. Indirect holding 139,000 shares/units after transaction. Holdings increased 40.40%.
Filing date: Apr 15, 2014. Record updated at 22:14:47.
 
Discovery Communications, Inc. (DISCA)
Senior Officer (Chief Financial Officer): Warren Andrew

Sold 3,104 Series A Common Stock (Non-Derivative security at $77.670) on Apr 11, 2014. Direct holding 17,527 shares/units after transaction. Holdings decreased -15.05%.
Filing date: Apr 15, 2014. Record updated at 22:10:58.
 
Workday, Inc. (WDAY)
Senior Officer (Senior Vice President): Bozzini James

Sold 5,937 Stock Option (right to buy) (Derivative security at conversion or exercise price: $0.250) on Apr 14, 2014. Direct holding 5,952 shares/units after transaction. Stock Option (right to buy) expires on May 9, 17. Holdings decreased -49.94%.
Filing date: Apr 15, 2014. Record updated at 22:06:53.
 
ARENA PHARMACEUTICALS INC (ARNA)
Director: Nova Tina Susan

Acquired 25,000 Common Stock (Non-Derivative security at $4.110) on Apr 14, 2014. Direct holding 43,728 shares/units after transaction. Holdings increased 133.49%.
Filing date: Apr 15, 2014. Record updated at 22:01:42.
 
Alliqua, Inc. (ALQA)
10% shareholder: CELGENE CORP /DE/

Acquired 714,286 Common Stock (Non-Derivative security at $7.000) on Apr 14, 2014. Direct holding 2,386,760 shares/units after transaction. Holdings increased 42.71%.
Filing date: Apr 14, 2014. Record updated at 19:10:20.
 
Read more

Disclaimer

InsidersLab.com focuses on tracking and monitoring insider trading activities in the US stocks market. "Insider Trading" means trading activities created by company directors, senior officers, individual substantial shareholders, and institutional shareholders. InsidersLab.com does not represent, warrant, nor endorse the accuracy, reliability, completeness or timeliness of any of the information, content, views, opinions, recommendations or advertisements (collectively, the "Materials") contained on, distributed through, or linked, downloaded or accessed from any of the services contained on the website (the "Service"), nor the quality of any products, information or other materials displayed, purchased, or obtained by you as a result of an advertisement or any other information or offer in or in connection with the Service (the "Products"). InsidersLab.com collects insider trading information from different public sources such as newspapers, financial information websites, and government statistics publications. You hereby acknowledge that any reliance upon any Materials shall be at your sole risk. In particular, none of the Materials is provided on the InsidersLab.com website or emails with a view to inviting, inducing or encouraging any person to make any kind of investment decision. Securities or other investments referred to in the Materials may not be suitable for you and you should not make any kind of investment decision in relation to them without first obtaining independent investment advice from a person authorized to give it.